Hepatic impairment (HI)
Clinical trials for Hepatic impairment (HI) explained in plain language.
Never miss a new study
Get alerted when new Hepatic impairment (HI) trials appear
Sign up with your email to follow new studies for Hepatic impairment (HI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver study tests how body handles experimental drug
Knowledge-focused CompletedThis early-stage study looks at how the experimental drug nemtabrutinib is processed in people with moderate liver impairment compared to healthy volunteers. About 32 adults will receive a single oral dose, and researchers will measure drug levels in the blood over time. The goal…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Sep 04, 2026 00:00 UTC
-
New drug EDG-7500 put to the test in liver health study
Knowledge-focused CompletedThis early-stage study is testing a single dose of an experimental drug called EDG-7500 in 32 adults. Some have mild or moderate liver problems, while others have normal liver function. Researchers want to see how the drug moves through the body and if it is safe in people with d…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase 1 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Liver function and drug safety: new study on varegacestat
Knowledge-focused CompletedThis study looked at how the drug varegacestat moves through the body in people with liver problems compared to healthy people. About 35 adults took a single dose, and researchers measured drug levels and side effects. The goal was to understand if liver impairment changes how th…
Matched conditions: HEPATIC IMPAIRMENT (HI)
Phase 1 • Sponsor: Immunome, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC